Drug Profile
Brinzolamide/travoprost
Alternative Names: Travoprost/brinzolamideLatest Information Update: 15 Apr 2019
Price :
$50
*
At a glance
- Originator Alcon
- Class Antiglaucomas; Prostaglandins; Sulfonamides; Thiazines
- Mechanism of Action Carbonic anhydrase inhibitors; Prostaglandin F2 alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Glaucoma; Ocular hypertension
Most Recent Events
- 09 Apr 2019 Novartis completed the spin-off of Alcon eye care devices business
- 27 Sep 2016 No recent reports on development identified - Phase-II for Glaucoma in USA (Ophthalmic)
- 27 Sep 2016 No recent reports on development identified - Phase-II for Ocular hypertension in USA (Ophthalmic)